Older age, HTN, DL, CKD, and PAD may contribute to anemia of chronic disease, potentially offsetting SGLT-2 inhibitor effects and reducing erythrocytosis risk [23]. This evidence concerns the gene SLC5A2 and hypertensive disorder.